UK Markets closed

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.01-0.02 (-0.33%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close6.03
Open5.95
Bid0.00 x 1000
Ask0.00 x 1100
Day's range5.91 - 5.95
52-week range5.82 - 9.83
Volume8,280
Avg. volume9,471
Market cap65.85M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference

    ORLANDO, Fla., January 04, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer, will present at the H.C. Wainwright Virtual BioConnect Conference.

  • Business Wire

    LENSAR to Present at Two Upcoming Investor Conferences

    ORLANDO, Fla., November 16, 2021--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences:

  • Business Wire

    LENSAR Announces Poster Presentations at the American Academy of Ophthalmology

    ORLANDO, Fla., November 12, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that two posters have been accepted for virtual presentation at the Annual Meeting of the American Academy of Ophthalmology (AAO) being held November 12-15, 2021.